Markets

GW Pharmaceuticals (GWPH) Jumps: Stock Rises 6.2% - Tale of the Tape

GW Pharmaceuticals plc ( GWPH ) was a big mover last session with its shares rising over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month's volatile price range of $66.16 to $71.49.

This biopharmaceutical company has seen no estimate revisions in the last 7 days. The Zacks Consensus Estimate hasn't been in trend either. Friday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

GW Pharmaceuticals currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Investors interested in the medical industry may consider other well-placed stocks like Cardica Inc. ( CRDC ), Eagle Pharmaceuticals Inc. ( EGRX ) and ICU Medical, Inc. ( ICUI ). All the three stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

GW PHARMA-ADR (GWPH): Free Stock Analysis Report

CARDICA INC (CRDC): Free Stock Analysis Report

EAGLE PHARMACT (EGRX): Free Stock Analysis Report

ICU MEDICAL INC (ICUI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ICUI EGRX GWPH

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More